Basal ganglia choline levels in depression and response to fluoxetine treatment: An in vivo proton magnetic resonance spectroscopy study

Biological Psychiatry

Volumn 41, Issue 8, 1997, Pages 837-843

  Renshaw, Perry F ^a,e,f   Lafer, Beny ^b,e   Babb, Suzann M ^a,e   Fava, Maurizio ^b,e   Stoll, Andrew L ^c,d,e   Christensen, James D ^a,e   Moore, Constance M ^a,e   Yurgelun Todd, Deborah A ^a,e   Bonello, Christina M ^a   Pillay, Srinivasan S ^a   Rothschild, Anthony J ^a,e   Nierenberg, Andrew A ^b,e   Rosenbaum, Jerrold F ^b,e   Cohen, Bruce M ^a,e  

^a MCLEAN HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Psychopharmacology Unit   (Canada)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e 74 Fenwood Road   (United States)

^f McLean Brain Imaging Center   (United States)

Author keywords

Basal ganglia; Choline; Fluoxetine; Magnetic resonance imaging; Magnetic resonance spectroscopy; Major depression

Indexed keywords

CHOLINE; CREATINE; FLUOXETINE;

ADULT; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG RESPONSE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BASAL GANGLIA; CHOLINE; DEPRESSION; FEMALE; FLUOXETINE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; PSYCHIATRIC STATUS RATING SCALES;

EID: 0343052685     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00256-9     Document Type: Article

References (39)

1. Billah MM, Anthes JC (1990): The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem J 269: 281-291.
2. Blusztajn JK, Wurtman RJ (1983): Choline and cholinergic neurons. Science 221:614-619.
3. Charles HC, Lazeyras F, Krishnan KRR, Boyko OB, Payne M, Moore D (1994): Brain choline in depression: In vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. Prog Neuropsychopharmacol Biol Psychiatry 18:1121-1127.
4. Cohen BM, Miller AL, Lipinski JF, Pope HG (1980): Lecithin in mania: A preliminary report. Am J Psychiatry 137:242-243.
5. Cohen BM, Lipinski JF, Altesman RI (1982): Lecithin in the treatment of mania: Double-blind, placebo controlled trials. Am J Psychiatry 139:1162-1164.
6. Cohen BM, Renshaw PF, Stoll AL, Wurtman RJ, Yurgelun-Todd D, Babb SM (1995): Decreased brain choline uptake in older adults: An in vivo proton magnetic resonance spectroscopy study. JAMA 274:902-907.
7. Cummings JL (1992): Depression and Parkinson's disease: A review. Am J Psychiatry 149:443-454.
8. Cummings JL (1993): The neuroanatomy of depression. J Clin Psychiatry 54(suppl.): 14-20.
9. Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichle ME (1992): A functional neuroanatomy of unipolar depression. J Neurosci 12:3628-3641.
10. Drevets WC (1994): Geriatric depression: Brain imaging correlates and pharmacologic considerations. J Clin Psychiatry 55(suppl. A):71-81.
11. Exton JH (1990): Signaling through phosphatidylcholine breakdown. J Biol Chem 256:1-4.
12. Fleiss JL, Cohen J, Everitt BS (1969): Large sample standard errors of kappa and weighted kappa. Psychol Bull 72:323-327.
13. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R (1989): Localized proton NMR spectroscopy in different regions of human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn Reson Med 11:47-63.
14. Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
15. Husain MM, McDonald WM, Doraiswamy PM, et al (1991): A magnetic resonance imaging study of putamen nuclei in major depression. Psychiatry Res: Neuroimaging 40:95-99.
16. Janowsky DS, El-Yousef MK, Davis JM, Sekerke HJ (1972): A cholinergic-adrenergic hypothesis of mania and depression. Lancet ii:632-635.
17. Janowsky DS, El-Yousef MK, Davis JM, Sekerke HJ (1973): Parasympathetic suppression of manic symptoms by physostigmine. Arch Gen Psychiatry 28:542-547.
18. Kikinis R, Shenton ME, Gerig G, et al (1992): Routine quantitative analysis of brain and cerebrospinal fluid spaces with MR imaging. J Magn Reson Imaging 2:619-629.
19. Klein J, Gonzalez R, Köppen A, Löffelholz K (1993): Free choline and choline metabolites in rat brain and body fluid: Sensitive determination and implications for choline supply to the brain. Neurochem Int 22:293-300.
20. Klunk WE, Xu CJ, Panchalingham K, McClure RJ, Pettegrew JW (1994): Analysis of magnetic resonance spectra by mole percent: Comparison to absolute units. Neurobiol Aging 15:133-140.
21. Krishnan KRR, McDonald WM, Escalona PR, et al (1992): Magnetic resonance imaging of the caudate nuclei in depression: Preliminary observations. Arch Gen Psychiatry 49:553-557.
22. Leiva DB (1990): The neurochemistry of mania: A hypothesis of etiology and a rationale for treatment. Prog Neuropsychopharmacol Biol Psychiatry 14:423-429.
23. 31P NMR spectroscopy. NMR Biomed 1:177-183.
24. Michaelis T, Merboldt KD, Bruhn J, Hänicke W, Frahm J (1993): Absolute concentrations of metabolites in the adult human brain in vivo: Quantification of localized proton MR spectra. Radiology 187:219-227.
25. Moonen CTW, von Kienlin M, van Zijl PCM, et al (1989): Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy. NMR Biomed 2:201-208.
26. Mooradian AD (1988): Blood-brain barrier transport of choline is reduced in the aged rat. Brain Res 440:328-332.
27. 31P chemical shift imaging of the human brain in normal volunteers. NMR Biomed 6:173-180.
28. Oldfield RC (1971): The assessment and analysis of handedness: The Edinburgh Inventory. Neuropsychologia 9:97-113.
29. Pelech SL, Vance DE (1989): Signal transduction via phosphatidylcholine cycles. Trends Biochem Sci 14:28-30.
30. Petroff OAC, Ogino T, Alger JR (1988): High-resolution proton magnetic resonance spectroscopy of rabbit brain: Regional metabolite levels and postmortem changes. J Neurochem 51:163-171.
31. Pillay SS, Yurgelun-Todd DA, Bonello CM, Fava M, Lafer B, Renshaw PF (1995): Decreased caudate nucleus volume is associated with severity of treatment refractory depression. Soc Magn Res Abstracts 2:1237.
32. Schreier HA (1982): Mania responsive to lecithin in a 13 year old girl. Am J Psychiatry 139:108-110.
33. Simmons ML, Frondoza GC, Coyle JT (1991): Immunocytochemical localization of N-acetyl aspartate. Neuroscience 45:37-45.
34. Spitzer RL, Williams JBW, Gibbon M, et al (1989): Structured Clinical Interview for DSM-III-R-Patient Edition (SCID-P, 9/1/89 Version). New York: Biometrics Research Department, New York Psychiatric Institute.
35. Stoll AL, Cohen BM, Hanin I (1991): Erythrocyte choline concentrations in psychiatrie disorders. Biol Psychiatry 29: 309-321.
36. Stoll AL, Renshaw PF, DeMicheli E, Wurtman R, Pillay SS, Cohen BM (1995): Choline ingestion increases the resonance of choline-containing compounds in human brain: An in vivo proton magnetic resonance study. Biol Psychiatry 37:170-174.
37. Stoll AL, Sachs GS, Cohen BM, Lafer B, Christensen JD, Renshaw PF (in press): Choline in the treatment of rapid-cycling bipolar disorder: Clinical and neurochemical findings in lithium treated patients. Biol Psychiatry.
38. Wurtman RJ (1992): Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends Neurosci 15:117-122.
39. Zeisel SH (1993): Choline phospholipids: Signal transduction and carcinogenesis. FASEB J 7:551-557.